Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2024
Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis
E T Zemanick, I Emerman, M McCreary, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
D R VanDevanter, S L Heltshe, J Spahr, et al.
Nature
|
July 6, 2000
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
C K Stover, P Warrener, D R VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 12, 2020
Building global development strategies for cf therapeutics during a transitional cftr modulator era
N Mayer-Hamblett, S van Koningsbruggen-Rietschel, D P Nichols, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2024
Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis
E T Zemanick, I Emerman, M McCreary, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis
D R VanDevanter, S L Heltshe, J Spahr, et al.
Nature
|
July 6, 2000
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
C K Stover, P Warrener, D R VanDevanter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 12, 2020
Building global development strategies for cf therapeutics during a transitional cftr modulator era
N Mayer-Hamblett, S van Koningsbruggen-Rietschel, D P Nichols, et al.
Page
of 4